Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) CEO Sells 5,000 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) CEO Jim Brown sold 5,000 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $29.47, for a total transaction of $147,350.00. Following the completion of the transaction, the chief executive officer now owns 15,716 shares in the company, valued at $463,150.52. The trade was a 24.14 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

USANA Health Sciences Trading Up 1.3 %

USANA Health Sciences stock traded up $0.38 during trading on Monday, hitting $29.97. The company had a trading volume of 287,508 shares, compared to its average volume of 169,645. The stock has a market cap of $571.21 million, a price-to-earnings ratio of 10.59, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87. USANA Health Sciences, Inc. has a 1-year low of $27.71 and a 1-year high of $50.32. The company’s 50 day simple moving average is $33.42 and its 200-day simple moving average is $36.47.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The business had revenue of $213.61 million during the quarter, compared to analysts’ expectations of $208.82 million. As a group, analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Institutional Trading of USANA Health Sciences

Several hedge funds have recently made changes to their positions in USNA. Public Employees Retirement System of Ohio increased its position in shares of USANA Health Sciences by 635.5% during the fourth quarter. Public Employees Retirement System of Ohio now owns 5,075 shares of the company’s stock worth $182,000 after acquiring an additional 4,385 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in USANA Health Sciences by 83.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 17,300 shares of the company’s stock worth $621,000 after purchasing an additional 7,877 shares in the last quarter. Millennium Management LLC purchased a new stake in USANA Health Sciences during the 4th quarter worth about $633,000. Lazard Asset Management LLC raised its position in USANA Health Sciences by 24,765.5% in the 4th quarter. Lazard Asset Management LLC now owns 7,211 shares of the company’s stock valued at $258,000 after purchasing an additional 7,182 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of USANA Health Sciences by 16.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 128,976 shares of the company’s stock valued at $4,629,000 after buying an additional 18,490 shares during the period. Institutional investors and hedge funds own 54.25% of the company’s stock.

Analysts Set New Price Targets

USNA has been the topic of a number of research analyst reports. Sidoti downgraded USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Finally, DA Davidson lowered their target price on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research note on Thursday.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.